Join Barchart Premier and get daily trading ideas and historical data downloads. FREE 30 Day Trial
or

Cytokinetics (CYTK)

Cytokinetics (CYTK)
37.85 x 2 39.01 x 45
Post-market by (Cboe BZX)
37.81 -0.12 (-0.32%) 04/22/25 [NASDAQ]
37.85 x 2 39.01 x 45
Post-market 37.81 unch (unch) 16:02 ET
Quote Overview for Tue, Apr 22nd, 2025
Watch
    Add or delete the symbol from one or more Watchlists.
Day Low
37.21
Day High
39.25
Open 38.59
Previous Close 37.93 37.93
Volume 2,089,900 2,089,900
Avg Vol 2,456,295 2,456,295
Stochastic %K 51.75% 51.75%
Weighted Alpha -44.03 -44.03
5-Day Change -2.00 (-5.02%) -2.00 (-5.02%)
52-Week Range 32.74 - 68.76 32.74 - 68.76
  • 1D
  • 5D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
  • MAX
Full Chart
  • OHLC Bars
  • Colored OHLC Bars
  • HLC Bars
  • Candlestick Hollow
  • Candlestick Open-to-Close
  • Candlestick Close-to-Close
  • Heikin-Ashi
  • Line Chart
  • Area Chart
  • Renko
  • Column
  • Baseline
  • Line Break
  • Range
  • Kagi
  • Point And Figure
Realtime quote and/or trades are not sourced from all markets.

Fundamentals

See More
  • Market Capitalization, $K 4,520,801
  • Shares Outstanding, K 119,188
  • Annual Sales, $ 18,470 K
  • Annual Income, $ -589,530 K
  • EBIT $ -536 M
  • EBITDA $ -527 M
  • 60-Month Beta 0.94
  • Price/Sales 254.71
  • Price/Cash Flow N/A
  • Price/Book N/A

Options Overview Details

View History
  • Implied Volatility 87.16% ( +2.67%)
  • Historical Volatility 59.89%
  • IV Percentile 92%
  • IV Rank 69.20%
  • IV High 110.92% on 04/09/25
  • IV Low 33.79% on 06/03/24
  • Put/Call Vol Ratio 0.12
  • Today's Volume 278
  • Volume Avg (30-Day) 2,851
  • Put/Call OI Ratio 0.20
  • Today's Open Interest 76,767
  • Open Int (30-Day) 73,974

Analyst Rating / Earnings Estimates

Current Rating
See More
Strong Buy
Based on 21 analysts offering recommendations.
Earnings Estimates - Current Qtr 03/31/25
See More
  • Average Estimate -1.41
  • Number of Estimates 12
  • High Estimate -1.22
  • Low Estimate -1.59
  • Prior Year -1.33
  • Growth Rate Est. (year over year) -6.02%

Price Performance

See More
Period Period Low Period High Performance
1-Month
32.74 +15.49%
on 04/09/25
Period Open: 45.43
48.43 -21.93%
on 03/24/25
-7.62 (-16.77%)
since 03/21/25
3-Month
32.74 +15.49%
on 04/09/25
Period Open: 46.82
52.80 -28.39%
on 01/27/25
-9.01 (-19.24%)
since 01/22/25
52-Week
32.74 +15.49%
on 04/09/25
Period Open: 66.29
68.76 -45.01%
on 04/23/24
-28.48 (-42.96%)
since 04/22/24

Most Recent Stories

More News
Cytokinetics to Announce First Quarter Results on May 6, 2025

CYTK : 37.81 (-0.32%)
Cytokinetics Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

CYTK : 37.81 (-0.32%)
Cytokinetics to Participate in the 24th Annual Needham Virtual Healthcare Conference

CYTK : 37.81 (-0.32%)
Cytokinetics Announces Launch of EARTH-HCM, a Public Health Education Tool for the Hypertrophic Cardiomyopathy Community

CYTK : 37.81 (-0.32%)
Cytokinetics Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

CYTK : 37.81 (-0.32%)
Cytokinetics Announces Five Presentations at the American College of Cardiology Annual Scientific Session & Expo

CYTK : 37.81 (-0.32%)
Cytokinetics to Participate in March Investor Conferences

CYTK : 37.81 (-0.32%)
Cytokinetics: Q4 Earnings Snapshot

Cytokinetics: Q4 Earnings Snapshot

CYTK : 37.81 (-0.32%)
Cytokinetics Reports Fourth Quarter 2024 Financial Results and Provides Business Update

CYTK : 37.81 (-0.32%)
Cytokinetics Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

CYTK : 37.81 (-0.32%)

Barchart Technical Opinion

The Barchart Technical Opinion rating is a 100% Sell with a Strongest short term outlook on maintaining the current direction.

Long term indicators fully support a continuation of the trend.

See More Share

Business Summary

Cytokinetics is a late-stage biopharmaceutical company focused on discovering, developing and commercializing first-in-class muscle activators as potential treatments for debilitating diseases in which muscle performance is compromised and/or deteriorating. With an unmatched understanding of muscle biology...

See More

Key Turning Points

3rd Resistance Point 40.99
2nd Resistance Point 40.12
1st Resistance Point 38.96
Last Price 37.81
1st Support Level 36.93
2nd Support Level 36.06
3rd Support Level 34.90

See More

52-Week High 68.76
Fibonacci 61.8% 55.00
Fibonacci 50% 50.75
Fibonacci 38.2% 46.50
Last Price 37.81
52-Week Low 32.74

See More

Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.
Use your up/down arrows to move through the symbols.
Free Barchart Webinar
Unlock High-Probability Trade Setups: Master Fractals & Time Frames Like a Pro